Introduction
When a crystalline pharmaceutical solid is subjected to different levels of relative humidity (RH), water vapor molecules in the atmosphere can be attached to its surface through van der Waals, ion-dipole or hydrogen bonding interactions. Study of water molecules absorbed on the well-defined crystalline surfaces, specifies the high tendency of water to form hydrogen bonds. The main cause for extensive interactions observed between water molecules and pharmaceutical solids, is thought to be the ability of water to act as both Lewis acid and base. [1] [2] [3] [4] [5] Several research conducted on pharmaceutical solids indicates that changes in water content and number of water molecules in the pharmaceutical solids can cause extensive variations in their physical and chemical properties, thereby reducing their pharmaceutical contributions. [6] [7] [8] [9] [10] For this reason, it is necessary to measure water content of pharmaceutical solids within each stage of the development process. Accordingly, water contents of Active Pharmaceutical Ingredients (APIs) and excipients are measured before and after mixing them together. 11 The tendency of solids to take up water vapor from the atmosphere with changes in RH at constant temperature, is often referred to as "hygroscopicity", the measurement of which is now a routine preformulation activity intended to provide an early assessment of the potential effects of moisture on the physical and chemical properties of drug candidates. [11] [12] [13] Once hygroscopicity was measured, one must select a suitable coating for drug package, so as to avoid moisture to penetrate into the pharmaceutical solids; thereby preventing possible changes to occur in the drug's characteristics. 14, 15 However, it is a point that seems to be neglected, as the findings of this research indicate that even packed pharmaceutical solids start to absorb water vapor from the atmosphere under high levels of relative humidity, representing ineffectiveness
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A B S T R A C T
Background: It is reported that the change in the number of water molecules in the crystalline mineral salts which is used as pharmaceutical ingredients, can cause variations in their physicochemical and pharmaceutical properties. The number of water molecules of these pharmaceutical ingredients is subordinate to Relative Humidity (RH) and temperature of the maintenance environments of the medicines. The aim of the present study was to investigate variation in water content of pharmaceutical solids including ferrous sulfate, barium sulfate and magnesium chloride in different percentage of RH and temperature. Methods: For this purpose, the pharmaceutical solids (both inside and outside the packaging) were subjected to various relative humidity at constant temperature for a given period of time, then change in their water content was determined with Thermo Gravimetry Analysis (TGA). To create a variety environments with different RH in constant temperature, the saturated salt solutions were put in a desiccator and the RH above mixtures of solids was determined with a Hygroscope at 25°C. Results: According to the results obtained from TGA, the water content of pharmaceutical solids studied in this research (ferrous sulfate, barium sulfate and magnesium chloride) changed in different RH and temperatures. Conclusion: It is necessary to determine water uptake of Active Pharmaceutical Ingredients (APIs) and excipients in each stage of pharmaceutical development process. Furthermore, these results could be used to select an appropriate packaging to avoid adverse effects caused by water absorption by pharmaceutical solids. In cases where this is not possible, the allowable range of relative humidity for each pharmaceutical solid should be noted on its package. of their packaging. As a result, it seems to be necessary to measure water uptake not only in the early stages of the pharmaceutical development process, but also after the packaging step was completed to ensure a proper packaging through which water may not penetrate. 16 Investigated in this study are the amounts of water uptake for two pharmaceutical formulations, namely ferrous sulfate tablet and barium sulfate powder, measured both inside and outside the packaging, together with the amounts of water uptake for two active pharmaceutical ingredients, namely magnesium chloride and ferrous sulfate, before reporting the obtained results. Water uptake in pharmaceutical solids is typically measured using gravimetric method, where solid sample is subjected to various levels of relative humidity at a constant temperature for a given period of time. The change in the weight of the solid, measured as a function of relative humidity, is then translated into a water vapor sorption. 11 To put it in simple terms, a pre-weighed sample is placed in a closed desiccator containing a saturated solution of an electrolyte (i.e., at a constant RH). Then the sample is periodically removed and weighted until a constant weight is attained. 17 Thermo Gravimetric Analysis (TGA) was used to determine moisture content of the solids, before and after being subjected to different levels of relative humidity. This technique measures the mass loss of the samples as a function of temperature or time.
18,19
Materials and Methods
Water vapor uptake in pharmaceutical solids (ferrous sulfate, barium sulfate and magnesium chloride) was measured in a desiccator. Various substances can be used to establish different levels of relative humidity inside a desiccator: saturated and unsaturated salt solutions, solutions with different percentages of sulfuric acid, solutions with different percentages of glycerol and etc. The advantages of using saturated salt solutions for humidity control is that they are, mostly, simple and inexpensive chemicals, available at an acceptable level of purity while, are not volatile. 1, 20 Accordingly, saturated salt solutions were used to establish different levels of relative humidity in this research. Table 1 presents the used salts and the required amount of each one for the preparation of the saturated solutions. The percentage of relative humidity depends on the temperature and salt concentration. Therefore, measurements must be performed at constant temperature so as to avoid changes in the established relative humidity. Pharmaceutical solids investigated in this study include FeSO 4 ,7H 2 O APIs, FeSO 4 tablets (inside and outside the packaging), BaSO 4 powder (inside and outside the packaging) and MgCl 2 , 6H 2 O APIs were exposed to different percentages of relative humidity inside the desiccator. In the following, each sample will be separately described.
Ferrous sulfate, hepta hydrate APIs FeSO 4 ,7H 2 O powder was exposed to different percentages of relative humidity (9.5, 33.8, 54.5, 66.4, 73.5 and 83.0%) at 25˚C for 4 days, during which time changes in its weight (due to sorption or desorption of water) were recorded.
After a constant weight was reached, changes in the number of molecules of water were determined by using TGA.
Ferrous sulfate tablets
Ferrous sulfate tablets, both inside and outside the packaging, were subjected to different percentages of relative humidity (34, 46, 63 and 83%) at 25˚C. Storage time was 10 days for those tablets out of the packaging, while it was 3 months for those packed. The samples were analyzed thermo gravimetrically.
Barium sulfate
Barium sulfate was studied, again inside and outside the packaging. Moistures levels employed in were 34, 46, 63 and 83%. Time to reach an equilibration with water vapor was 3 months for the packed barium sulfate, while it was 10 days for unpacked barium sulfate. It should be noted that the time listed for each drug is the time required to reach equilibrium with water vapor in the atmosphere. A number of factors influenced this time: 1) the ratio of open surface of the solution to volume of the chamber, 2) air flow rate, 3) absorption characteristics of the sample, and 4) activity of saturated salt solution. 20 Based on the four factors mentioned, the time to reach equilibrium varied for different solids. After reaching equilibrium, TGA was used to determine sorption of the samples with the mass loss observed in the TGA spectra directly linked to the water content of the solids. Figure 1 
Results and Discussion
Ferrous sulfate
Ferrous sulfate tablet
Continuing with this study, ferrous sulfate tablets were investigated both inside and outside the packaging, the results of which are indicated in terms of TGA spectra shown in Figure4 (for tablets out of the pack) and Figure5 (for tablets inside the pack), Presenting ferrous sulfate tablets stored under relative humidity of 83.0%, Figure 4d shows a greater mass loss compared to that in Figure 4a -c which present tablets stored under relative humidity percentages of of 34, 46 and 63%, respectively. In addition, showing a mass loss at lower temperatures, the shape of the spectrum in Figure 4d is different from those of the other spectra. These observations express that the tablet uptakes moisture at a relative humidity of 83%. Shown in Figure 3 is the image of ferrous sulfate tablet after being placed under a relative humidity of 83%. This difference can be seen even in the packed ferrous sulfate tablets placed under different percentages of relative humidity (34, 46, 63 and 83%). Comparing the spectrum of the tablet stored under relative humidity of 83% (Figure 5d ) to other spectra, shows a greater mass loss. The results obtained from this investigation proved unsuitability of the selected packaging through which the moisture has penetrated and absorbed by the pharmaceutical solid. Therefore, in order to avoid adverse effects of water uptake by the pharmaceuticals, more appropriate material should be chosen for the packaging of tablets with the allowable range of relative humidity written on the package; this range should be less than 80%. Figure 6 shows TGA spectrum of the barium sulfate stored in the lab where due to absence of water molecules in the structure of BaSO 4 , as well as its stability against heat, a little mass loss is observed in the spectra. However, when different levels of relative humidity (34, 46, 63 and 83%) are applied to the drug at 25˚C, a greater mass loss is observed in TGA spectra. See Figure7a-d.
Barium sulfate
Continuing with the investigation, the packed barium sulfate was placed under different percentages of relative humidity while water uptake behavior of the drug was being monitored. The results are presented in Figure8. Increased amount of mass loss in Figures8a-d shows that some amount of moisture is absorbed by barium sulfate even when it is inside the package, so that the packaging provides inappropriate means to prevent the moisture from penetrating into the drug. It is worth mentioning that magnesium chloride, as a pharmaceutical solid, is usually sold without any packaging; however, as demonstrated in this study, this compound tends to absorb a large amount of moisture from the environment even at as low relative humidity percentages as 34%. So, it is necessary to wrap it in an appropriate package and keep it under relative humidity percentages of less than 34%.
Conclusion
A change in the number of water molecules in pharmaceutical solids can cause variations in their physicochemical and pharmaceutical properties. Investigated in this study were the effect of two major factors, namely relative humidity and temperature, on the number of water molecules in three pharmaceutical solids including ferrous sulfate, barium sulfate and magnesium chloride. For this purpose, they were placed under different percentages of relative humidity before incorporating thermo gravimetric analysis. The results of investigations show that the water content of pharmaceutical solids can change under different percentages of relative humidity, so that it is necessary to determine water uptake of APIs and excipients in each stage of pharmaceutical development process. Furthermore, these results could be used to select an appropriate packaging to avoid adverse effects caused by water absorption by pharmaceutical solids. In cases where this is not possible, the allowable range of relative humidity for each pharmaceutical solid should be noted on its package. The appropriate ranges of relative humidity were found to be less than 80% for ferrous sulfate tablets, 50-80% for ferrous sulfate APIs, and less than 34% for barium sulfate and magnesium chloride.
